A detailed history of Ameritas Investment Partners, Inc. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 8,418 shares of IDYA stock, worth $214,995. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,418
Previous 7,323 14.95%
Holding current value
$214,995
Previous $257,000 3.5%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$30.37 - $43.05 $33,255 - $47,139
1,095 Added 14.95%
8,418 $266,000
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $26,155 - $33,073
761 Added 11.6%
7,323 $257,000
Q1 2024

May 13, 2024

BUY
$34.2 - $47.13 $11,354 - $15,647
332 Added 5.33%
6,562 $287,000
Q4 2023

Feb 14, 2024

BUY
$24.59 - $35.83 $20,532 - $29,918
835 Added 15.48%
6,230 $221,000
Q3 2023

Nov 13, 2023

BUY
$21.07 - $29.77 $19,194 - $27,120
911 Added 20.32%
5,395 $145,000
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $12,530 - $23,998
940 Added 26.52%
4,484 $105,000
Q4 2022

Feb 13, 2023

BUY
$14.47 - $18.17 $14,296 - $17,951
988 Added 38.65%
3,544 $64,000
Q3 2021

Nov 15, 2021

BUY
$17.26 - $27.08 $6,127 - $9,613
355 Added 16.13%
2,556 $65,000
Q2 2021

Aug 06, 2021

BUY
$17.76 - $24.83 $13,213 - $18,473
744 Added 51.06%
2,201 $46,000
Q1 2021

May 14, 2021

BUY
$13.48 - $23.77 $5,324 - $9,389
395 Added 37.19%
1,457 $34,000
Q2 2020

Aug 05, 2020

BUY
$3.59 - $18.57 $3,812 - $19,721
1,062 New
1,062 $15,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.23B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.